Comparative Pharmacology
Head-to-head clinical analysis: PEPCID COMPLETE versus PEPCID PRESERVATIVE FREE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PEPCID COMPLETE versus PEPCID PRESERVATIVE FREE.
PEPCID COMPLETE vs PEPCID PRESERVATIVE FREE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Famotidine competitively inhibits histamine at H2-receptors of gastric parietal cells, reducing gastric acid secretion. Calcium carbonate and magnesium hydroxide act as antacids to neutralize existing gastric acid.
Competitive antagonist of histamine at H2 receptors on gastric parietal cells, inhibiting gastric acid secretion.
One tablet (famotidine 10mg, calcium carbonate 800mg, magnesium hydroxide 165mg) orally once daily, taken 30 minutes before a meal that causes heartburn.
20 mg intravenously over at least 2 minutes or as an infusion over 15-30 minutes every 12 hours; alternatively, 20 mg orally once or twice daily.
None Documented
None Documented
2.5-3.5 hours (prolonged to 12-20 hours in severe renal impairment, CrCl <10 mL/min).
2.5-3.5 hours (normal renal function); prolonged to 20-30 hours in severe renal impairment (CrCl <10 mL/min). Clinical context: dose adjustment required in renal insufficiency.
Renal: 65-70% (famotidine unchanged); fecal: 30-35% (as metabolites). Biliary elimination is minimal (<5%).
Renal (65-70% unchanged by tubular secretion); minor biliary/fecal elimination (<30%). Clearance correlates with creatinine clearance.
Category C
Category C
H2 Receptor Antagonist
H2 Receptor Antagonist